Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck (Q71647966)
Jump to navigation
Jump to search
scientific article published on 01 July 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck |
scientific article published on 01 July 1994 |
Statements
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group (English)
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck (English)
M. Clavel
J. B. Vermorken
F. Cognetti
P. Cappelaere
P. H. de Mulder
J. H. Schornagel
E. A. Tueni
J. Verweij
J. Wildiers